About Coherex
Coherex is a company based in Salt Lake City (United States) founded in 2003 was acquired by Biosense Webster in November 2015. Coherex has raised $25.03 million across 2 funding rounds from investors including BioSense Webster, Tullis Health Investors and Signal Peak. The company has 19 employees as of December 31, 2016. Coherex operates in a competitive market with competitors including PECA Labs, Xeltis, Occlutech, Endonovo Therapeutics and AdvancedCPR Solutions, among others.
- Headquarter Salt Lake City, United States
- Employees 19 as on 31 Dec, 2016
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Coherex Medical, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$25.03 M (USD)
in 2 rounds
-
Latest Funding Round
$16.5 M (USD), Series B
Aug 20, 2009
-
Investors
BioSense Webster
& 3 more
-
Employee Count
19
as on Dec 31, 2016
-
Acquired by
Biosense Webster
(Nov 20, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Coherex
Coherex has successfully raised a total of $25.03M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $16.5 million completed in August 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Coherex
Coherex has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include BioSense Webster, Tullis Health Investors and Signal Peak.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare investments are made by Tullis Health Investors.
|
Locked | Locked | Locked | |
|
Early-stage investments in US tech and life sciences are targeted.
|
Locked | Locked | Locked | |
|
Early stage VC firm investing in the US and Korea
|
Locked | Locked | Locked |
Investor details for Coherex
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Coherex
Investment portfolio details for Coherex
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Coherex
Detailed financials for Coherex
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Coherex Comparisons
Peer comparison for Coherex
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Coherex
Coherex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PECA Labs, Xeltis, Occlutech, Endonovo Therapeutics and AdvancedCPR Solutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pediatric cardiac surgical devices are developed for congenital heart defects.
|
|
| Locked | Locked | Locked |
Developer of bioabsorbable synthetic heart valves and vascular grafts
|
|
| Locked | Locked | Locked |
Provider of minimally invasive cardiac devices for congenital heart defects, stroke prevention and heart failure
|
|
| Locked | Locked | Locked |
Bioelectronic devices are developed for regenerative medicine therapies.
|
|
| Locked | Locked | Locked |
CPR products for sudden cardiac arrest treatment are developed.
|
Detailed competitors of Coherex
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Coherex
Complete news archive for Coherex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Coherex
Coherex was founded in 2003 and raised its 1st funding round 4 years after it was founded.
Coherex is headquartered in Salt Lake City, United States. It is registered at Salt Lake City, Utah, United States.
Coherex is a funded company, having raised a total of $25.03M across 2 funding rounds to date.
As of Dec 31, 2016, the latest employee count at Coherex is 19.
Medical devices for structural heart disease were developed by Coherex Medical, Inc., founded as Proximare, Inc. in 2003 and renamed in 2006. A patent foramen ovale closure system was created to promote tissue in-growth for sustained closure. Operations focused on cardiovascular implants in the medtech sector. The company, based in Salt Lake City, United States, was acquired by Johnson Johnsons Biosense Webster in November 2015.
Coherex's top competitors include Xeltis, PECA Labs and Endonovo Therapeutics.
Coherex has 4 investors. Key investors include BioSense Webster, Tullis Health Investors, Signal Peak, and Oxford Bioscience Partners.